y 27632 has been researched along with Ocular Hypotension in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahler, CK; Fautsch, MP; Holman, BH; Roddy, GW; Roy Chowdhury, U; Sheikh-Hamad, D; Stamer, WD; Viker, KB; Winkler, NS | 1 |
1 other study(ies) available for y 27632 and Ocular Hypotension
Article | Year |
---|---|
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.
Topics: Aged; Aged, 80 and over; Amides; Animals; Anterior Eye Segment; Antihypertensive Agents; Blotting, Western; Cell Line; Gene Expression Regulation; Glycoproteins; Humans; Intraocular Pressure; Latanoprost; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Middle Aged; Ocular Hypotension; Prostaglandins F, Synthetic; Pyridines; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Tonometry, Ocular | 2017 |